Tag: Biotechnology

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Another alliance of health care and AI signals why pharma stocks should be back in favor

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

CNBC’s Becky Quick details daughter’s rare disease journey